Two papers challenge exclusion of acupuncture in government guidelines

April 28, 2017

New Rochelle, NY, April 28, 2017-- Even as news in the United States recently highlighted the growing inclusion of acupuncture and other complementary and integrative medicine therapies in guidelines for multiple pain conditions, the exclusion of acupuncture in two British governmental guidelines is challenged in a paper and a commentary that are presently available free on The Journal of Alternative and Complementary Medicine (JACM) website until May 29, 2017.

In "The U.K. NICE 2014 Guidelines for Osteoarthritis of the Knee: Lessons Learned in a Narrative Review Addressing Inadvertent Limitations and Bias," an international team of co-authors led by Netherlands researcher Stephen Birth, PhD challenge the UK's National Institute for Healthcare Excellence (NICE) for holding acupuncture to a higher evidentiary standard than other modalities. The authors also challenge the panel's decision to focus on clinical trials with sham acupuncture, given that the sham methods are known to not be inert, thus diminishing the "effect size" of acupuncture.

In an invited JACM commentary on this guideline and another on low-back pain and sciatica that also excluded acupuncture, United Kingdom acupuncture researcher Hugh MacPherson, PhD, MBAcC also takes the NICE panel to task for also being "compromised by inconsistent application of criteria between interventions for different modalities." The commentary is entitled "NICE for Some Interventions, But Not So NICE for Others: Questionable Guidance on Acupuncture for Osteoarthritis and Low-Back Pain."

"While the authors fall short of accusing the NICE panel of intentional bias, it is dumbfounding and deeply unfortunate in a time of advancing awareness of the public harm from over-reliance on pharmaceuticals in pain treatment that NICE should choose to stack the deck against the significant evidence for acupuncture as another tool," says The Journal of Alternative and Complementary Medicine Editor-in-Chief John Weeks, johnweeks-integrator.com, Seattle, WA.
-end-
About the Journal

The Journal of Alternative and Complementary Medicine (JACM) is a monthly peer-reviewed journal published online with open access options and in print. Led by John Weeks (johnweeks-integrator.com), the Co-founder and past Executive Director of the Academic Collaborative for Integrative Health, the Journal provides observational, clinical, and scientific reports and commentary intended to help healthcare professionals, delivery organization leaders, and scientists evaluate and integrate therapies into patient care protocols and research strategies. Complete tables of content and a sample issue may be viewed on The Journal of Alternative and Complementary Medicine website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Alternative and Complementary Therapies, Medical Acupuncture, and Journal of Medicinal Food. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc./Genetic Engineering News

Related Osteoarthritis Articles from Brightsurf:

Major savings possible with app-based osteoarthritis treatment
Osteoarthritis treatment conducted digitally via an app costs around 25% of what conventional care costs, according to a study from Lund University in Sweden published in the research journal PLOS ONE.

New approach to treating osteoarthritis advances
Injections of a natural 'energy' molecule prompted regrowth of almost half of the cartilage lost with aging in knees, a new study in rodents shows.

Bone drug may be beneficial for knee osteoarthritis
Bisphosphonates (a class of drugs that prevent the loss of bone density and used to treat osteoporosis and similar diseases) appear to be safe and beneficial for osteoarthritis patients.

Certain jobs linked to higher risk of knee osteoarthritis
Workers in jobs that typically involve heavy lifting, frequent climbing, prolonged kneeling, squatting, and standing face an increased risk of developing knee osteoarthritis.

App helps reduce osteoarthritis pain
By performing a few simple physical exercises daily, and receiving information about their disease regularly, 500 osteoarthritis patients were able to on average halve their pain in 6 months -- and improve their physical function.

Osteoarthritis can increase your risk for social isolation
In a study published in the Journal of the American Geriatrics Society, researchers examined information from the European Project on OSteoArthritis (EPOSA) study.

High rates of opioid prescriptions for osteoarthritis
Opioids work against severe pain but the risks of side effects and addiction are high.

Disease burden in osteoarthritis is similar to rheumatoid arthritis
Osteoarthritis (OA) has traditionally been viewed as a highly prevalent but milder condition when compared with rheumatoid arthritis (RA), and some may believe that it is part of a normal aging process requiring acceptance, not treatment.

3D printing may help treat osteoarthritis
In a Journal of Orthopaedic Research study, scientists used 3D printing to repair bone in the joints of mini-pigs, an advance that may help to treat osteoarthritis in humans.

Finger joint enlargements may be linked to knee osteoarthritis
Heberden's nodes (HNs) are bony enlargements of the finger joints that are readily detectable in a routine physical exam and are considered hallmarks of osteoarthritis.

Read More: Osteoarthritis News and Osteoarthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.